BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31797753)

  • 21. Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
    Ucal Y; Tokat F; Duren M; Ince U; Ozpinar A
    Thyroid; 2019 Aug; 29(8):1125-1137. PubMed ID: 31064269
    [No Abstract]   [Full Text] [Related]  

  • 22. Utility of Tumor Capsule Thickness as a Predictor of Invasion in Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and a Diagnostic Tool for Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features.
    French B; Hattier G; Mardekian SK
    Int J Surg Pathol; 2020 Feb; 28(1):13-19. PubMed ID: 31256687
    [No Abstract]   [Full Text] [Related]  

  • 23. HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.
    Sadiq Q; Sekhri R; Dibaba DT; Zhao Q; Agarwal S
    World J Surg Oncol; 2021 May; 19(1):143. PubMed ID: 33964951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
    Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
    Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
    Kopczyński J; Suligowska A; Niemyska K; Pałyga I; Walczyk A; Gąsior-Perczak D; Kowalik A; Hińcza K; Mężyk R; Góźdź S; Kowalska A
    Endocr Pathol; 2020 Jun; 31(2):143-149. PubMed ID: 32236858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms.
    Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
    Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
    Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
    Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A diagnostic model based on DNA methylation haplotype block characteristics for identifying papillary thyroid carcinoma from thyroid adenoma.
    Xu D; Lai Y; Liu H; Li H; Feng N; Liu Y; Gong C; Zhang Y; Zhou J; Shen Y
    Transl Res; 2024 Feb; 264():76-84. PubMed ID: 37863284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.
    Macerola E; Poma AM; Vignali P; Proietti A; Torregrossa L; Ugolini C; Basolo A; Matrone A; Elisei R; Santini F; Basolo F
    J Endocrinol Invest; 2023 Aug; 46(8):1651-1662. PubMed ID: 36749451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma.
    Siraj AK; Pratheeshkumar P; Parvathareddy SK; Bu R; Masoodi T; Iqbal K; Al-Rasheed M; Al-Dayel F; Al-Sobhi SS; Alzahrani AS; Al-Dawish M; Al-Kuraya KS
    Eur J Cancer; 2019 Aug; 117():133-144. PubMed ID: 31280122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digital image-assisted quantitative nuclear analysis improves diagnostic accuracy of thyroid fine-needle aspiration cytology.
    Chain K; Legesse T; Heath JE; Staats PN
    Cancer Cytopathol; 2019 Aug; 127(8):501-513. PubMed ID: 31150162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
    Dolezal JM; Trzcinska A; Liao CY; Kochanny S; Blair E; Agrawal N; Keutgen XM; Angelos P; Cipriani NA; Pearson AT
    Mod Pathol; 2021 May; 34(5):862-874. PubMed ID: 33299111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
    Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC.
    Point du Jour K; du Jour KP; Schmitt AC; Chen AY; Griffith CC
    Endocr Pathol; 2018 Mar; 29(1):35-42. PubMed ID: 29368294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of BRAFV600E as a diagnostic adjuvant in the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Johnson DN; Sadow PM
    Hum Pathol; 2018 Dec; 82():32-38. PubMed ID: 30146440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EphB3 protein is a potential ancillary diagnostic biomarker for thyroid cancers.
    Gao X; Zhang R; He Y; Wang X; Bao W; Feng X; Chai J; Wang J
    Ann Diagn Pathol; 2024 Apr; 69():152262. PubMed ID: 38150866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors.
    Bisarro Dos Reis M; Barros-Filho MC; Marchi FA; Beltrami CM; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4089-4099. PubMed ID: 28938489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a review for clinicians.
    Rosario PW; Mourão GF
    Endocr Relat Cancer; 2019 May; 26(5):R259-R266. PubMed ID: 30913533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
    Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
    Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features.
    Legesse T; Parker L; Heath J; Staats PN
    J Am Soc Cytopathol; 2019; 8(1):11-17. PubMed ID: 30929754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.